Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-02-04Clinical Trial Update: Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib
A clinical trial investigating biomarkers in pulmonary arterial hypertension treated with nilotinib has been withdrawn.
-
FDA label_change · 2014-01-31FDA Approved: REVATIO — Supplemental Application (PFIZER LABORATORIES DIV PFIZER INC)
The FDA approved a supplemental application for REVATIO (sildenafil citrate) filed by Pfizer Laboratories Division Pfizer Inc, resulting in …
-
FDA approval · 2014-01-31FDA Approved: LETAIRIS — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for LETAIRIS (ambrisentan) submitted by Gilead Sciences, Inc.
-
FDA approval · 2014-01-31FDA Approved: REVATIO — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for REVATIO (sildenafil citrate) submitted by Viatris Specialty LLC.
-
FDA approval · 2014-01-31FDA Approved: REVATIO — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for REVATIO (sildenafil citrate) from Viatris Specialty LLC, updating labeling for the product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension [Phase 4]
A Phase 4 study evaluating intravenous treprostinil (Remodulin) for pulmonary arterial hypertension in India was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers [Phase 1]
A Phase 1 safety study evaluating oral aminophylline and ambrisentan, both alone and in combination, in healthy volunteers to assess tolerab…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography [NA]
This update reports the completion of a clinical trial from George Washington University evaluating estimation of pulmonary vascular resista…
-
FDA approval · 2014-01-03FDA Approved: REMODULIN — Supplemental Application (United Therapeutics Corporation)
FDA approved a supplemental application for REMODULIN (treprostinil) from United Therapeutics Corporation.
-
FDA approval · 2013-12-20FDA Approved: ORENITRAM — Original Application (United Therapeutics Corporation)
The FDA approved ORENITRAM (treprostinil) under an Original NDA from United Therapeutics, providing an oral formulation for pulmonary arteri…
-
FDA approval · 2013-11-20FDA Approved: ADCIRCA — Supplemental Application (United Therapeutics Corporation)
The FDA approved a supplemental application for ADCIRCA (tadalafil) submitted by United Therapeutics Corporation.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension [Phase 4]
Phase 4 trial evaluating the efficacy and safety of adding sildenafil to bosentan for pulmonary arterial hypertension has completed.
-
FDA approval · 2013-10-18FDA Approved: OPSUMIT — Original Application (Actelion Pharmaceuticals US, Inc.)
FDA approved OPSUMIT (macitentan) under the original application, for the treatment of pulmonary arterial hypertension.
-
FDA approval · 2013-10-08FDA Approved: ADEMPAS — Original Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved Adempas (riociguat) from Bayer as the original application for treatment of pulmonary arterial hypertension and chronic thr…
-
FDA approval · 2013-09-26FDA Approved: REMODULIN — Supplemental Application (United Therapeutics Corporation)
FDA approved a supplemental application for REMODULIN (treprostinil) from United Therapeutics Corporation.
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler) [Phase 1]
Phase 1 clinical trial evaluating Echo-Doppler sonar technology to measure blood pressure in the lung circulation for pulmonary arterial hyp…
-
FDA approval · 2013-08-17FDA Approved: LETAIRIS — Supplemental Application (Gilead Sciences, Inc.)
The FDA granted approval of a supplemental application for LETAIRIS (ambrisentan) from Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) [Phase 3]
A Phase 3 clinical trial investigated inhaled treprostinil sodium for severe pulmonary arterial hypertension; results were posted after comp…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: The Study Of CT Scans and Echo Parameters in Patients With PAH
A study evaluating CT scans and echocardiography parameters in patients with pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Treprostinil Combined With Tadalafil for Pulmonary Hypertension [Phase 4]
This update reports the termination of a Phase 4 trial evaluating the combination of treprostinil and tadalafil for pulmonary arterial hyper…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH [Phase 4]
Phase 4 trial exploring safety, efficacy, and treatment satisfaction when switching PAH patients from Flolan to Remodulin using the Crono Fi…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Imatinib (QTI571) in Pulmonary Arterial Hypertension [Phase 3]
Phase 3 trial of Imatinib for pulmonary arterial hypertension has completed with results posted in 2013.
-
CLINICAL_TRIALS research · 2013-07-15Clinical Trial Update: Effects of Apelin on the Lung Circulation in Pulmonary Hypertension [NA]
This clinical trial update examines the effects of apelin on lung circulation in pulmonary arterial hypertension. Heart failure is listed am…
-
CLINICAL_TRIALS withdrawal · 2013-07-08Clinical Trial Update: Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
A clinical trial investigating stress echocardiography to detect pulmonary arterial hypertension in systemic sclerosis patients has been wit…
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
This completed trial from the University of Zurich studied whether smoking is a risk factor for pulmonary arterial hypertension.